Diane Gardiner
Corporate Officer/Principal presso BC Human Resources Management Association
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Michael McElhaugh | M | 50 | 10 anni | |
Tricia Hollyer | F | - |
BC Human Resources Tech Group
BC Human Resources Management Association
| - |
Richard Henriques | M | 68 | 10 anni | |
David Haber | M | - |
BC Human Resources Management Association
| - |
Patricia Watson | F | - |
BC Human Resources Management Association
| - |
Paula Bifano | F | - |
BC Human Resources Management Association
| - |
Len Posyniak | M | 68 |
BC Human Resources Management Association
| - |
Mike W. Cass | M | - |
BC Human Resources Management Association
| - |
Warren H. Wong | M | - |
BC Human Resources Management Association
| - |
Stacy Shields | F | - |
BC Human Resources Management Association
| - |
Korina Kinsman | F | - |
BC Human Resources Management Association
| - |
Gus A. Butow | M | - |
BC Human Resources Management Association
| - |
Norah Joyce | F | - |
BC Human Resources Management Association
| - |
Terrence J. Schmaltz | M | - |
BC Human Resources Management Association
| - |
Michael Sofia | M | 66 | 9 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Kamran Alam | M | 50 |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada.
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases.
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 15 anni |
Ken Galbraith | M | 61 |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | 5 anni |
Peggy Phillips | F | 70 | 1 anni | |
Bruce Cousins | M | 63 | 5 anni | |
Geoffrey W. Henson | M | 76 |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | 7 anni |
Jodi Regts | F | - |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | 5 anni |
William T. Symonds | M | 56 | 4 anni | |
Ian MacLachlan | M | - | 6 anni | |
Elisabeth Whiting | F | - |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | 5 anni |
Mark Levonyak | M | - |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | 1 anni |
Paul Brennan | M | - |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | 4 anni |
Ian Mortimer | M | 48 | 16 anni | |
Mark Kowalski | M | 69 | 3 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Canada | 19 | 67.86% |
Stati Uniti | 11 | 39.29% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Diane Gardiner
- Contatti personali